Olivier Huillard

3.2k total citations
84 papers, 1.4k citations indexed

About

Olivier Huillard is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Olivier Huillard has authored 84 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 36 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in Olivier Huillard's work include Renal cell carcinoma treatment (16 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Prostate Cancer Treatment and Research (12 papers). Olivier Huillard is often cited by papers focused on Renal cell carcinoma treatment (16 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Prostate Cancer Treatment and Research (12 papers). Olivier Huillard collaborates with scholars based in France, United States and Sweden. Olivier Huillard's co-authors include François Goldwasser, Pascaline Boudou‐Rouquette, Jérôme Alexandre, Camille Tlemsani, Benoı̂t Blanchet, Olivier Mir, Stanislas Ropert, Julie Giroux, Marc Zerbib and Michaël Peyromaure and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and American Journal of Clinical Nutrition.

In The Last Decade

Olivier Huillard

77 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier Huillard France 20 540 438 313 311 227 84 1.4k
Antonella Brunello Italy 23 907 1.7× 474 1.1× 184 0.6× 354 1.1× 67 0.3× 119 1.8k
Stanislas Ropert France 26 1.1k 2.0× 757 1.7× 365 1.2× 729 2.3× 64 0.3× 67 2.5k
Michael P. Chu Canada 21 570 1.1× 246 0.6× 195 0.6× 308 1.0× 40 0.2× 66 1.2k
Gabriella Farina Italy 24 1.0k 1.9× 785 1.8× 204 0.7× 293 0.9× 39 0.2× 65 1.8k
Maartje Los Netherlands 26 996 1.8× 746 1.7× 239 0.8× 320 1.0× 45 0.2× 80 2.0k
Anna M. Button United States 20 367 0.7× 161 0.4× 353 1.1× 299 1.0× 38 0.2× 42 1.3k
Michael W. Schuster United States 29 1.1k 2.1× 208 0.5× 481 1.5× 1.3k 4.0× 92 0.4× 94 3.2k
Se‐Il Go South Korea 24 583 1.1× 337 0.8× 344 1.1× 245 0.8× 20 0.1× 74 1.4k
Keiichiro Nakamura Japan 28 606 1.1× 186 0.4× 110 0.4× 495 1.6× 74 0.3× 105 2.1k
Paul Sieber United States 27 689 1.3× 1.3k 2.9× 131 0.4× 273 0.9× 300 1.3× 75 2.3k

Countries citing papers authored by Olivier Huillard

Since Specialization
Citations

This map shows the geographic impact of Olivier Huillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Huillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Huillard more than expected).

Fields of papers citing papers by Olivier Huillard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Huillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Huillard. The network helps show where Olivier Huillard may publish in the future.

Co-authorship network of co-authors of Olivier Huillard

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Huillard. A scholar is included among the top collaborators of Olivier Huillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Huillard. Olivier Huillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Auclin, Édouard, Clément Dumont, H. Gauthier, et al.. (2026). Real-World Outcomes of First-Line Immune-Based Combination Therapies in Bone-Metastatic Clear Cell Renal Cell Carcinoma. Clinical Genitourinary Cancer. 24(2). 102506–102506.
2.
Jouinot, Anne, Nadim Hamzaoui, Olivier Huillard, et al.. (2025). Predisposition to prostate cancer and clinical implications in a real-life cohort. European Journal of Human Genetics. 33(9). 1163–1172.
3.
Puszkiel, Alicja, Jennifer Arrondeau, Pascaline Boudou‐Rouquette, et al.. (2024). Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients. British Journal of Cancer. 130(11). 1866–1874. 7 indexed citations
4.
Arrondeau, Jennifer, Anne Jouinot, Pascaline Boudou‐Rouquette, et al.. (2023). Impact of sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors. Clinical Nutrition. 42(6). 944–953. 10 indexed citations
5.
Huillard, Olivier, Nihel Khoudour, Benoı̂t Blanchet, et al.. (2023). Cardiac toxicity associated with pharmacokinetic drug–drug interaction between crizotinib and sofosbuvir/velpatasvir: A case report. British Journal of Clinical Pharmacology. 89(4). 1486–1490. 3 indexed citations
6.
Groussin, Lionel, Fidéline Bonnet-Serrano, Béatrix Cochand‐Priollet, et al.. (2022). Redifferentiating Effect of Larotrectinib in NTRK -Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer. Thyroid. 32(5). 594–598. 35 indexed citations
7.
Jouinot, Anne, Jérôme Alexandre, Marie Bretagne, et al.. (2022). Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab. Cancers. 14(13). 3214–3214. 2 indexed citations
8.
Dufresne, Armelle, Olivier Huillard, Cécile Dalban, et al.. (2022). 465P Larotracking: Real-life study of locally advanced/metastatic solid tumor treated with larotrectinib in French expanded access program. Annals of Oncology. 33. S753–S753. 2 indexed citations
9.
Colomba, Émeline, Grégoire Marret, Giulia Baciarello, et al.. (2020). Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome. European Journal of Cancer. 129. 117–122. 11 indexed citations
10.
11.
Gross‐Goupil, Marine, Valérie Seegers, Benoit Beuselinck, et al.. (2020). Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study. European Journal of Cancer. 136. 76–83. 20 indexed citations
12.
13.
Tardy, Magalie P., R. Delva, Pernelle Lavaud, et al.. (2018). Neuroendocrine carcinoma of the urinary bladder: A large analysis of the French GETUG consortium. Annals of Oncology. 29. viii321–viii322. 1 indexed citations
14.
Blanchet, Benoı̂t, Mohammad Alyamani, Lisa Golmard, et al.. (2018). A PK/PD study of Delta-4 abiraterone metabolite in metastatic castration-resistant prostate cancer patients. Pharmacological Research. 136. 56–61. 11 indexed citations
15.
Mazières, Julien, Fabrice Barlési, Bruno Coudert, et al.. (2018). OA12.05 Vemurafenib in Patients Harboring V600 and Non V600 BRAF Mutations: Final Results of the NSCLC Cohort from the AcSé Trial.. Journal of Thoracic Oncology. 13(10). S348–S349. 7 indexed citations
16.
Berdelou, A., Isabelle Borget, Yann Godbert, et al.. (2017). Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice. Thyroid. 28(1). 72–78. 102 indexed citations
17.
Bretagne, Marie, Anne Jouinot, Jean-Philippe Durand, et al.. (2017). Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity. Cancer Chemotherapy and Pharmacology. 80(1). 45–53. 19 indexed citations
18.
Lavaud, Pernelle, Benoı̂t Rousseau, Jennifer Arrondeau, et al.. (2016). Bi-weekly very-high-dose lapatinib: an easy-to-use active option in HER-2-positive breast cancer patients with meningeal carcinomatosis. Breast Cancer Research and Treatment. 157(1). 191–192. 12 indexed citations
19.
Bretagne, Marie, Pascaline Boudou‐Rouquette, Olivier Huillard, et al.. (2016). Inhibiteurs de tyrosine kinase ciblant l’angiogenèse et sujets âgés : tolérance, évaluation pré-thérapeutique et gestion des effets indésirables. Bulletin du Cancer. 103(3). 259–272. 4 indexed citations
20.
Huillard, Olivier, Jérôme Alexandre, & François Goldwasser. (2016). Treatment of Advanced Renal-Cell Carcinoma.. New England Journal of Medicine. 374(9). 888–888. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonella Brunello Breakdown of academic impact, for papers by Stanislas Ropert Breakdown of academic impact, for papers by Michael P. Chu Breakdown of academic impact, for papers by Gabriella Farina Breakdown of academic impact, for papers by Maartje Los Breakdown of academic impact, for papers by Anna M. Button Breakdown of academic impact, for papers by Michael W. Schuster Breakdown of academic impact, for papers by Se‐Il Go Breakdown of academic impact, for papers by Keiichiro Nakamura Breakdown of academic impact, for papers by Paul Sieber
Rankless by CCL
2026